article thumbnail

FTC and DOJ Report on Merger Trends in 2023: A Year of Big Deals and Big Scrutiny

Complex Discovery

These enforcement actions targeted critical sectors, including pharmaceuticals, healthcare, technology, and energy. Energy and natural resources accounted for 7.1% , followed by chemicals and pharmaceuticals at 4.8%. Health services and transportation each made up 3.6% For instance, the FTC challenged Amgen’s $27.8

article thumbnail

M&A in 2025: What January’s HSR Transactions Signal for the Year Ahead

Complex Discovery

Healthcare Sector: Pharmaceutical Mergers and Digital Health Investments Surge The healthcare sector is experiencing strong consolidation trends, particularly among pharmaceutical firms, medical device manufacturers, and digital health companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Riding the M&A Wave: What February’s 230 HSR Transactions Reveal About Economic Trends and Risk Management

Complex Discovery

Healthcare and Pharma Consolidation: With regulatory shifts and technological advancements in biotech, pharmaceutical mergers are increasing, driven by both innovation and cost-saving incentives.

article thumbnail

Lawyering in a Time of Lawlessness (And Also Probably Cholera)

Ethicking

Being willing to work many, many hours a week on pharmaceutical mergers or whatever does not mean being willing to work on criminalizing gender transitions or disappearing people because theyre fans of Real Madrid who happen to be brown. How is Paul, Weiss exercising its professional independence, as required?